Sabra Health Care REIT is experiencing robust revenue growth, with Q2 2026 revenue up 24.7% YoY to $235.9M, driven by portfolio expansion and occupancy gains. However, earnings quality is questionable as FFO per share plummeted 71.4% YoY to $0.12, and AFFO of ...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 3, 2026 | -$0.10-158.4% vs $0.17 | $236M+7.5% vs $219M |
Q2 2026 Apr 29, 2026 | $0.16-4.0% vs $0.17 | $222M+6.0% vs $209M |
Q1 2026 Feb 12, 2026 | $0.11-35.3% vs $0.17 | $212M+7.0% vs $198M |
Q4 2025 Nov 5, 2025 | $0.09-48.7% vs $0.18 | $190M+1.7% vs $187M |
Tidal Investments LLC lifted its stake in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 204.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,958 shares of the real estate investment trust's stock after acquiring an additional 25,477 shares during the quarter. Tidal
Sabra Health Care REIT remains a Buy, supported by improving fundamentals and an attractive valuation amid a strategic pivot to managed senior housing. SBRA reported Q2 2026 normalized AFFO of $0.40 per share, a ~5% YoY increase, with occupancy rising to 85.4% and guidance reaffirmed. Significant investments—$599 million YTD at ~7.5% yield—position SBRA for the Silver Tsunami, despite near-term macro and rate headwinds.
Sabra Health Care REIT is rated 'Buy' with a $24.50/share price target, reflecting undervaluation and strong fundamentals. SBRA reported robust Q2 results: 24.7% revenue growth, 13.7% same-store managed senior housing NOI growth, and reaffirmed 2026 AFFO guidance. Recent acquisitions totaling $599 million at attractive yields, a healthy balance sheet, and ample liquidity support ongoing external growth.
Senior Housing REITs are outperforming major indices, driven by a persistent supply-demand imbalance and favorable demographic trends. This article previews 3 Senior Housing REITs that offer high yields and strong balance sheets while trading at attractive FFO multiples. All three REITs present robust internal and external growth potential as occupancy rates climb, with yields well above Treasury rates.
Benchmark SBRA against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Sabra Health Care REIT, Inc. (SBRA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $19.69 | $4.97B | 30.77 | 10.15% | 20.09% | 5.59% | 6.01% | |
| $229.94 | $165.69B | 165.42 | 35.82% | 10.67% | 3.08% | — | |
| $86.64 | $42.12B | 160.44 | 18.47% | 4.13% | 1.99% | — | |
| $46.17 | $13.75B | 23.80 | 13.95% | 66.43% | 15.76% | — | |
| $42.54 | $2.18B | 16.88 | 25.26% | 38.92% | 11.45% | — | |
| $37.17 | $8.78B | 23.68 | 108.79% | 65.4% | 8.51% | — |
Sabra Health Care REIT, Inc. (SBRA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Sabra Health Care REIT, Inc. (SBRA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 3, 2026·SEC
Jul 21, 2026·SEC
Jun 17, 2026·SEC
Get notified when SBRA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Sabra Health Care REIT, Inc. (SBRA) stock FAQ — growth, dividends, profitability & financials explained
Sabra Health Care REIT, Inc. (SBRA) reported $859.6M in revenue for fiscal year 2025. This represents a 9668% increase from $8.8M in 2010.
Sabra Health Care REIT, Inc. (SBRA) grew revenue by 10.2% over the past year. This is steady growth.
Yes, Sabra Health Care REIT, Inc. (SBRA) is profitable, generating $65.4M in net income for fiscal year 2025 (20.1% net margin).
Yes, Sabra Health Care REIT, Inc. (SBRA) pays a dividend with a yield of 6.01%. This makes it attractive for income-focused investors.
Sabra Health Care REIT, Inc. (SBRA) has a return on equity (ROE) of 5.6%. This is below average, suggesting room for improvement.
Sabra Health Care REIT, Inc. (SBRA) generated Funds From Operations (FFO) of $274.9M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Sabra Health Care REIT, Inc. (SBRA) offers a 6.01% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.
